Literature DB >> 30797881

Nybomycin-producing Streptomyces isolated from carpenter ant Camponotus vagus.

Yuliya V Zakalyukina1, Mikhail V Birykov2, Dmitrii A Lukianov3, Dmitrii I Shiriaev4, Ekaterina S Komarova5, Dmitry A Skvortsov4, Yury Kostyukevich3, Vadim N Tashlitsky4, Vladimir I Polshakov6, Eugene Nikolaev3, Petr V Sergiev7, Ilya A Osterman8.   

Abstract

A novel strain of Actinomycetes was isolated from the body of an ant (Camponotus vagus Scopoli) and its genetic and morphological properties were characterized. The 16S rDNA gene sequence analysis of the isolate revealed its high phylogenetic relationship with type strains of Streptomyces violaceochromogenes NBRC 13100T. As a result of antimicrobial activity assessment, it was found that the fermentation broth of the isolated strain both inhibited the growth and induced the SOS response in E. coli BW25113 ΔtolC strain cells. Using bioassay-guided fractionation, mass spectrometric and NMR analyses we identified the active compound to be nybomycin, a previously described antibiotic. Here we report for the first time Streptomyces producer of nybomycin in association with carpenter ants and demonstrate cytotoxic activity of nybomycin against human cell lines.
Copyright © 2019 Elsevier B.V. and Société Française de Biochimie et Biologie Moléculaire (SFBBM). All rights reserved.

Entities:  

Keywords:  Actinobacteria; Antibacterial activity; Ants; Camponotus; Nybomycin; Reporter strain; Streptomyces

Mesh:

Substances:

Year:  2019        PMID: 30797881     DOI: 10.1016/j.biochi.2019.02.010

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  6 in total

1.  Nybomycin inhibits both types of E. coli DNA gyrase - fluoroquinolone-sensitive and fluoroquinolone-resistant.

Authors:  Dmitrii I Shiriaev; Alina A Sofronova; Ekaterina A Berdnikovich; Dmitrii A Lukianov; Ekaterina S Komarova; Valeria I Marina; Yuliya V Zakalyukina; Mikhail V Biryukov; Tinashe P Maviza; Yan A Ivanenkov; Petr V Sergiev; Ilya A Osterman; Olga A Dontsova
Journal:  Antimicrob Agents Chemother       Date:  2021-02-16       Impact factor: 5.191

2.  Structure Determination, Functional Characterization, and Biosynthetic Implications of Nybomycin Metabolites from a Mining Reclamation Site-Associated Streptomyces.

Authors:  Xiachang Wang; Sherif I Elshahawi; Larissa V Ponomareva; Qing Ye; Yang Liu; Gregory C Copley; James C Hower; Bruce E Hatcher; Madan K Kharel; Steven G Van Lanen; Qing-Bai She; S Randal Voss; Jon S Thorson; Khaled A Shaaban
Journal:  J Nat Prod       Date:  2019-12-13       Impact factor: 4.050

3.  Binding and Action of Triphenylphosphonium Analog of Chloramphenicol upon the Bacterial Ribosome.

Authors:  Chih-Wei Chen; Julia A Pavlova; Dmitrii A Lukianov; Andrey G Tereshchenkov; Gennady I Makarov; Zimfira Z Khairullina; Vadim N Tashlitsky; Alena Paleskava; Andrey L Konevega; Alexey A Bogdanov; Ilya A Osterman; Natalia V Sumbatyan; Yury S Polikanov
Journal:  Antibiotics (Basel)       Date:  2021-04-05

4.  Triphenilphosphonium Analogs of Chloramphenicol as Dual-Acting Antimicrobial and Antiproliferating Agents.

Authors:  Julia A Pavlova; Zimfira Z Khairullina; Andrey G Tereshchenkov; Pavel A Nazarov; Dmitrii A Lukianov; Inna A Volynkina; Dmitry A Skvortsov; Gennady I Makarov; Etna Abad; Somay Y Murayama; Susumu Kajiwara; Alena Paleskava; Andrey L Konevega; Yuri N Antonenko; Alex Lyakhovich; Ilya A Osterman; Alexey A Bogdanov; Natalia V Sumbatyan
Journal:  Antibiotics (Basel)       Date:  2021-04-23

5.  Amycolatopsis camponoti sp. nov., new tetracenomycin-producing actinomycete isolated from carpenter ant Camponotus vagus.

Authors:  Yuliya V Zakalyukina; Ilya A Osterman; Jacqueline Wolf; Meina Neumann-Schaal; Imen Nouioui; Mikhail V Biryukov
Journal:  Antonie Van Leeuwenhoek       Date:  2022-02-26       Impact factor: 2.158

6.  Observation of the Antimicrobial Activities of Two Actinomycetes in the Harvester Ant Messor orientalis.

Authors:  Yiyang Wu; Yaxuan Liu; Jinyong Yu; Yijuan Xu; Siqi Chen
Journal:  Insects       Date:  2022-07-31       Impact factor: 3.139

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.